Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Oct;16(4):351–357. doi: 10.1111/j.1365-2125.1983.tb02177.x

Drug epidemiology and clinical pharmacology: their contribution to patient care.

J Crooks
PMCID: PMC1428045  PMID: 6626431

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong B., Skegg D., White G., Doll R. Rauwolfia derivatives and breast cancer in hypertensive women. Lancet. 1976 Jul 3;2(7975):8–12. doi: 10.1016/s0140-6736(76)92966-4. [DOI] [PubMed] [Google Scholar]
  2. Armstrong B., Stevens N., Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet. 1974 Sep 21;2(7882):672–675. doi: 10.1016/s0140-6736(74)93258-9. [DOI] [PubMed] [Google Scholar]
  3. Bateson M. C., Crooks J., Hamley J. G., Leach R., MacConnachie A., Newton R. W., Tudhope G. R. Experience with a hospital formulary. Health Bull (Edinb) 1981 Jan;39(1):45–50. [PubMed] [Google Scholar]
  4. Bouchier I. A. Peptic ulcer: the changing scene. Scott Med J. 1981 Oct;26(4):297–302. doi: 10.1177/003693308102600402. [DOI] [PubMed] [Google Scholar]
  5. CROOKS J., CLARK C. G., CAIE H. B., MAWSON W. B. PRESCRIBING AND ADMINISTRATION OF DRUGS IN HOSPITAL. Lancet. 1965 Feb 13;1(7381):373–378. doi: 10.1016/s0140-6736(65)91800-3. [DOI] [PubMed] [Google Scholar]
  6. Christopher L. J., Crooks J., Davidson J. F., Erskine Z. G., Gallon S. C., Moir D. C., Weir R. D. A multicentre study of rauwolfia derivates and breast cancer. Eur J Clin Pharmacol. 1977 Jul 19;11(6):409–417. doi: 10.1007/BF00562930. [DOI] [PubMed] [Google Scholar]
  7. Crooks J., Weir R. D., Coull D. C., McNab J. W., Calder G., Barnett J. W., Caie H. B. Evaluation of a method of prescribing drugs in hospital, and a new method of recording their administration. Lancet. 1967 Mar 25;1(7491):668–671. doi: 10.1016/s0140-6736(67)92557-3. [DOI] [PubMed] [Google Scholar]
  8. Gibson I. I. Hospital drugs in the home. Gerontol Clin (Basel) 1974;16(1):10–13. doi: 10.1159/000245479. [DOI] [PubMed] [Google Scholar]
  9. Hamley J. G., Brown S. V., Crooks J., Christopher L. J., Dingwall D., Murdoch J. C., Knox J. D., Patterson A. W. Duplicate prescriptions: an aid to research and review. J R Coll Gen Pract. 1981 Nov;31(232):648–650. [PMC free article] [PubMed] [Google Scholar]
  10. Heinonen O. P., Shapiro S., Tuominen L., Turunen M. I. Reserpine use in relation to breast cancer. Lancet. 1974 Sep 21;2(7882):675–677. doi: 10.1016/s0140-6736(74)93259-0. [DOI] [PubMed] [Google Scholar]
  11. Kewitz H., Jesdinsky H. J., Schröter P. M., Lindtner E. Reserpine and breast cancer in women in germany. Eur J Clin Pharmacol. 1977 Jan 3;11(2):79–83. doi: 10.1007/BF00562896. [DOI] [PubMed] [Google Scholar]
  12. Lilienfeld A. M., Chang L., Thomas D. B., Levin M. L. Rauwolfia derivatives and breast cancer. Johns Hopkins Med J. 1976 Aug;139(2):41–50. [PubMed] [Google Scholar]
  13. Mack T. M., Henderson B. E., Gerkins V. R., Arthur M., Baptista J., Pike M. C. Reserpine and breast cancer in a retirement community. N Engl J Med. 1975 Jun 26;292(26):1366–1371. doi: 10.1056/NEJM197506262922603. [DOI] [PubMed] [Google Scholar]
  14. O'Fallon W. M., Labarthe D. R., Kurland L. T. Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota. Lancet. 1975 Aug 16;2(7929):292–296. doi: 10.1016/s0140-6736(75)92730-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. O'Malley K., Stevenson I. H., Ward C. A., Wood A. J., Crooks J. Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):309–314. doi: 10.1111/j.1365-2125.1977.tb00718.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Parkin D. M., Henney C. R., Quirk J., Crooks J. Deviation from prescribed drug treatment after discharge from hospital. Br Med J. 1976 Sep 18;2(6037):686–688. doi: 10.1136/bmj.2.6037.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shepherd A. M., Hewick D. S., Moreland T. A., Stevenson I. H. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):315–320. doi: 10.1111/j.1365-2125.1977.tb00719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wood A. J., Moir D. C., Campbell C., Davidson J. F., Gallon S. C., Henney E., McAllion S. Medicines evaluation and monitoring group: central nervous system effects of pentazocine. Br Med J. 1974 Feb 23;1(5903):305–307. doi: 10.1136/bmj.1.5903.305. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES